⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GNPX News
Genprex, Inc. Common Stock
Form 8-K
sec.gov
GNPX
Form 8-K
sec.gov
GNPX
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting
prnewswire.com
GNPX
Form 8-K
sec.gov
GNPX
Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting
prnewswire.com
GNPX
Form 8-K
sec.gov
GNPX
Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
prnewswire.com
GNPX
Form 8-K
sec.gov
GNPX
Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting
prnewswire.com
GNPX
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting
prnewswire.com
GNPX